SCHEMBL23770800

SCHEMBL23770800

Cc1cccc(C)c1-c1nc(NSc2cccc(N3CCC(O)(C(=O)O)CC3)n2)ccc1Cl

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.32
SMO Q99835 2/20 0.32
PTPN11 Q06124 6/20 0.31
CNR1 P21554 2/20 0.31
CNR2 P34972 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
PTGER4 P35408 2/20 0.30
CCNT1 O60563 1/20 0.30
CDK4 P11802 1/20 0.30
CCND1 P24385 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770874 0.91 SMO (0.31) SMOPTPN11HDAC3HDAC4HDAC1
SCHEMBL23770659 0.91 PTPN11 (0.36) SMOPTPN11CNR1CNR2HDAC3
SCHEMBL23770844 0.91 PTPN11 (0.33) RORCSMOPTPN11CNR1CNR2
SCHEMBL23770837 0.85 SMO (0.34) SMOCNR1CNR2MEN1KMT2A
SCHEMBL19970116 0.84 DGAT1 (0.35) PTPN11CNR1CNR2
SCHEMBL23770829 0.84 HDAC3 (0.33) SMOPTPN11CNR1HDAC3HDAC4
SCHEMBL19970119 0.82 AURKA (0.32) CNR1CNR2
SCHEMBL23770843 0.82 SMO (0.33) SMOPTPN11HDAC3HDAC4HDAC1
SCHEMBL23770450 0.82 HTR3E (0.43) SMOPTPN11CCNT1CDK4CCND1
SCHEMBL23770785 0.81 LMNA (0.43) SMOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed